Format

Send to:

Choose Destination

Apolipoprotein C-III

A 9-kDa protein component of VERY-LOW-DENSITY LIPOPROTEINS and CHYLOMICRON REMNANTS. Apo C-III, synthesized in the liver, is an inhibitor of LIPOPROTEIN LIPASE. Apo C-III modulates the binding of chylomicron remnants and VLDL to receptors (RECEPTORS, LDL) thus decreases the uptake of triglyceride-rich particles by the liver cells and subsequent degradation. The normal Apo C-III is glycosylated. There are several polymorphic forms with varying amounts of SIALIC ACID (Apo C-III-0, Apo C-III-1, and Apo C-III-2).

Year introduced: 2007

PubMed search builder options

Subheadings:

Tree Number(s): D10.532.091.400.875, D12.776.070.400.400.875, D12.776.521.120.400.875

MeSH Unique ID: D053305

Entry Terms:

  • Apolipoprotein C III
  • Apolipoprotein CIII
  • Apo C-III
  • Apo C III
  • Apolipoprotein C-III-1
  • Apolipoprotein C III 1
  • ApoC-III
  • ApoC III
  • Apolipoprotein C-III-0
  • Apolipoprotein C III 0
  • Sialyl Apo C-III
  • Apo C-III, Sialyl
  • Sialyl Apo C III
  • Sialyl Apolipoprotein C-III
  • Apolipoprotein C-III, Sialyl
  • Sialyl Apolipoprotein C III
  • Apo C-III-2
  • Apo C III 2

Previous Indexing:

Supplemental Content

Loading ...
Support Center